• Users Online: 121
  • Print this page
  • Email this page
Year : 2022  |  Volume : 2  |  Issue : 2  |  Page : 138-142

BRAF/Mitogen-activated extracellular signal-related kinase inhibitors induced sarcoid-like reaction in patients with refractory localized conjunctival melanoma: A rare case report

1 National Ophthalmic Pathology Laboratory, Royal Victoria Eye and Ear Hospital; Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin, Ireland; School of Biotechnology, Dublin City University, Dublin, Ireland
2 Department of Oncology, St. Vincent's University Hospital, Dublin, Ireland

Correspondence Address:
Dr. Susan Kennedy
National Ophthalmic Pathology Laboratory, Royal Victoria Eye and Ear Hospital, Adelaide Road, Dublin 2

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jpo.jpo_14_22

Rights and Permissions

We present a rare case of a patient with refractory localized conjunctival melanoma (CM) who was treated with BRAF/mitogen-activated extracellular signal-related kinase inhibitors in the absence of systemic metastasis. The patient had complete remission and developed a local sarcoid-like reaction. To our knowledge, this is the first report of this complication in a patient with locally advanced CM which emphasizes the local complication of BRAF inhibition.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded16    
    Comments [Add]    

Recommend this journal